Abstract
In the Netherlands prenatal screening is offered as a mean to increase reproductive choices of couples. All women are counseled on the existing options by trained midwives. The government puts a great emphasis on informed choice and on womens' opinions and reactions to screenings options. Since 2017 non-invasive prenatal testing (NIPT, cf-DNA) is offered as first tier screening for aneuploidies in the genome-wide (GW) variant at the cost of 175 Euro's. Uptake is around 50%. This screenings offer is perceived as unconventional for the traditionally cautious Dutch system.
Original language | English |
---|---|
Pages (from-to) | 941-944 |
Number of pages | 4 |
Journal | Journal of Perinatal Medicine |
Volume | 49 |
Issue number | 8 |
Early online date | 2021 |
DOIs | |
Publication status | Published - 1 Oct 2021 |